Anne E. Goodbody

1.2k total citations
19 papers, 861 citations indexed

About

Anne E. Goodbody is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Anne E. Goodbody has authored 19 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Anne E. Goodbody's work include Alkaloids: synthesis and pharmacology (5 papers), Adipose Tissue and Metabolism (5 papers) and Chemical synthesis and alkaloids (5 papers). Anne E. Goodbody is often cited by papers focused on Alkaloids: synthesis and pharmacology (5 papers), Adipose Tissue and Metabolism (5 papers) and Chemical synthesis and alkaloids (5 papers). Anne E. Goodbody collaborates with scholars based in United Kingdom, Canada and United States. Anne E. Goodbody's co-authors include Paul Trayhurn, Masanaru Misawa, Tsuyoshi Endo, Michael J. Stock, Nancy J. Rothwell, Vasken Dilsizian, Steven R. Bergmann, Timothy M. Bateman, James E. Udelson and J. P. KUTNEY and has published in prestigious journals such as Nature, Circulation and Biochemical Journal.

In The Last Decade

Anne E. Goodbody

19 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne E. Goodbody United Kingdom	16	350	218	169	137	126	19	861
K. R. L. Mansford United Kingdom	12	137 0.4×	286 1.3×	72 0.4×	46 0.3×	44 0.3×	28	697
I.F. Skidmore United Kingdom	16	341 1.0×	308 1.4×	15 0.1×	25 0.2×	94 0.7×	37	870
Toshihiko Yanagisawa Japan	9	104 0.3×	128 0.6×	54 0.3×	11 0.1×	27 0.2×	21	494
Elwood Largis United States	16	308 0.9×	422 1.9×	11 0.1×	46 0.3×	169 1.3×	30	977
Peter B. Colligan United States	9	127 0.4×	219 1.0×	12 0.1×	19 0.1×	39 0.3×	11	545
Pascale Beffy Italy	16	81 0.2×	335 1.5×	21 0.1×	26 0.2×	33 0.3×	36	717
Oliver Schnorr Germany	11	171 0.5×	155 0.7×	25 0.1×	36 0.3×	18 0.1×	14	575
Durga K. Bhuyan United States	16	276 0.8×	807 3.7×	65 0.4×	116 0.8×	77 0.6×	23	1.1k
Wang Fun Fong Hong Kong	16	83 0.2×	675 3.1×	20 0.1×	84 0.6×	31 0.2×	25	936
Yasuhide Kontani Japan	12	292 0.8×	173 0.8×	6 0.0×	57 0.4×	74 0.6×	16	535

Countries citing papers authored by Anne E. Goodbody

Since Specialization

Citations

This map shows the geographic impact of Anne E. Goodbody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E. Goodbody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E. Goodbody more than expected).

Fields of papers citing papers by Anne E. Goodbody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne E. Goodbody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E. Goodbody. The network helps show where Anne E. Goodbody may publish in the future.

Co-authorship network of co-authors of Anne E. Goodbody

This figure shows the co-authorship network connecting the top 25 collaborators of Anne E. Goodbody. A scholar is included among the top collaborators of Anne E. Goodbody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne E. Goodbody. Anne E. Goodbody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Schwarz, Sally W., et al.. (2018). Harmonization of U.S., European Union, and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals: Is This Possible?. Journal of Nuclear Medicine. 60(2). 158–166. 17 indexed citations

Dilsizian, Vasken, Timothy M. Bateman, Steven R. Bergmann, et al.. (2005). Metabolic Imaging With β-Methyl- p -[ ¹²³ I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia. Circulation. 112(14). 2169–2174. 146 indexed citations

Caveliers, Vicky, et al.. (2001). Evaluation of 99mTc-RP128 as a potential inflammation imaging agent: human dosimetry and first clinical results.. PubMed. 42(1). 154–61. 20 indexed citations

Paul, Carolyn, et al.. (2000). The detection and quantitation of inflammation in the central nervous system during experimental allergic encephalomyelitis using the radiopharmaceutical 99mTc-RP128. Journal of Neuroscience Methods. 98(1). 83–90. 10 indexed citations

Pollak, Alfred, Anne E. Goodbody, James R. Ballinger, et al.. (1996). Imaging inflammation with 99Tcm-labelled chemotactic peptides. Nuclear Medicine Communications. 17(2). 132–139. 18 indexed citations

Goodbody, Anne E., et al.. (1988). Enzymic Coupling of Catharanthine and Vindoline to form 3′,4′-Anhydrovinblastine by Horseradish Peroxidase. Planta Medica. 54(2). 136–140. 31 indexed citations

Goodbody, Anne E., et al.. (1988). Production of 3', 4'-anhydrovinblastine: a unique chemical synthesis. Tetrahedron. 44(2). 325–331. 73 indexed citations

Goodbody, Anne E., et al.. (1988). The Coupling of Catharanthine and Vindoline to Form 3′,4′-Anhydrovinblastine by Haemoproteins and Haemin. Planta Medica. 54(3). 210–214. 10 indexed citations

Goodbody, Anne E., et al.. (1988). Extraction of 3′,4′-anhydrovinblastine from Catharanthus roseus. Phytochemistry. 27(6). 1713–1717. 17 indexed citations

10.

Endo, Tsuyoshi, et al.. (1988). Enzymes from Catharanthus roseus cell suspension cultures that couple vindoline and catharanthine to form 3′,4′-anhydrovinblastine. Phytochemistry. 27(7). 2147–2149. 37 indexed citations

11.

Misawa, Masanaru, Tsuyoshi Endo, Anne E. Goodbody, et al.. (1988). Synthesis of dimeric indole alkaloids by cell free extracts from cell suspension cultures of Catharanthus roseus. Phytochemistry. 27(5). 1355–1359. 35 indexed citations

12.

Goodbody, Anne E., et al.. (1987). Serpentine release by suspension cultures of Catharanthus roseus. Biotechnology Letters. 9(9). 629–632. 7 indexed citations

13.

Endo, Tsuyoshi, Anne E. Goodbody, & Masanaru Misawa. (1987). Alkaloid Production in Root and Shoot Cultures ofCatharanthus roseus. Planta Medica. 53(5). 479–482. 57 indexed citations

14.

Endo, Tsuyoshi, et al.. (1987). Biotransformation of anhydrovinblastine to vinblastine by a cell-free extract of Catharanthus roseus cell suspension cultures. Phytochemistry. 26(12). 3233–3234. 15 indexed citations

15.

Trayhurn, Paul, et al.. (1982). A role for brown adipose tissue in the genesis of obesity? Studies on experimental animals. Proceedings of The Nutrition Society. 41(2). 127–131. 15 indexed citations

16.

Trayhurn, Paul, et al.. (1982). Effects of overfeeding on energy balance and brown fat thermogenesis in obese (ob/ob) mice. Nature. 295(5847). 323–325. 101 indexed citations

17.

Goodbody, Anne E. & Paul Trayhurn. (1982). Studies on the activity of brown adipose tissue in suckling, pre-obese, obob mice. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 680(2). 119–126. 45 indexed citations

18.

Goodbody, Anne E. & Paul Trayhurn. (1981). GDP binding to brown-adipose-tissue mitochondria of diabetic-obese (db/db) mice. Decreased binding in both the obese and pre-obese states. Biochemical Journal. 194(3). 1019–1022. 70 indexed citations

19.

Rothwell, Nancy J., et al.. (1980). Increased proton conductance pathway in brown adipose tissue mitochondria of rats exhibiting diet-induced thermogenesis. Nature. 286(5770). 274–276. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact